Citation Tools

Download PDFPDF

561 Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer
Free

Download to a citation manager

Cite this article as:
Anderson K, Su Y, Burnett M, et al
561 Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer